Command Palette

Search for a command to run...

Clinical Trials · NCT01324388

A Study of the Effect of LY2189265 on Two Blood Pressure Drugs

CompletedPhase 1Dulaglutide (Approved)
Phase
Phase 1
Recruitment status
Completed
Sponsor
Eli Lilly and Company
Enrollment
51
Start date
Mar 2011
Locations
3 sites, United States
Primary endpoint
Pharmacokinetics, Area Under the Concentration Curve (AUC) of Lisinopril
View Dulaglutide compound reference